is semaglutide glp-1 Another Weight-Loss Trial Win for Weekly Drug Types of GLP-1 Medications for

they help reset your relationship with food and improve overall health from the inside out

Nausea is the most common side effect, with frequency varying by specific medication and dose

GLP1 RA Mechanisms of Action and Weight Loss As of January 2025, there are three incretin mimetic medications approved for treatment of overweight and obesity: liraglutide, semaglutide, and tirzepatide

Peptide therapy is recognised for its high safety and low side-effect profile compared to traditional medications or supplements

Together, these effects help with blood sugar control and how the body uses and stores energy

Tirzepatide targets GLP-1 and GIP receptors, while semaglutide targets only GLP-1 receptors